COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary DiseaseKatherine Lowe, Karin F. Hoth, Surya P. Bhatt et al.|Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation|2019Cited by 181
Pathobiont-driven antibody sialylation through IL-10 undermines vaccinationChih‐Ming Tsai, George Y. Liu, Irshad A. Hajam et al.|Journal of Clinical Investigation|2024Cited by 12
525: Elexacaftor/tezacaftor/ivacaftor therapy alters the CF lung mucus metabolome, reshaping microbiome niche spaceRobert A. Quinn, Douglas Conrad, Lauren M. Sosinski et al.|Journal of Cystic Fibrosis|2021Cited by 1
Microenvironmental effects of a non-antibiotic therapy for a chronic Polymicrobial infection Alter microbial physiology, competition, and virulenceCely T. Gonzalez, Robert A. Quinn, Christian Martin et al.|The ISME Journal|2025Cited by 1